11 terminated. 11 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 11 | Terminated 11 |
| Phase 1 | 1 | Terminated 1 |
Follow Testicular Diseases: new trials by email Literature Review of Testicular Diseases trials Research Report on Testicular Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Durvalumab Alone or With Tremelimumab in Refractory Germ Cell Tumors Durvalumab, Tremelimumab - Germ Cell Tumor | Phase 2 | Terminated | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 36 | 2017-02-01 | 2021-05-14 |
| Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors Brentuximab Vedotin - Germ Cell Tumors, Testis Cancer | Phase 2 | Terminated | Nabil Adra | 18 | 2016-03-09 | 2019-12-10 |
| Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors Pembrolizumab - Germ Cell Neoplasms, Testicular Neoplasms | Phase 2 | Terminated | Nasser Hanna, M.D. | 12 | 2016-01-01 | 2022-07-11 |
| Testis CAB: Cabazitaxel as Salvage Treatment for Cisplatin-resistant Germ Cell Cancer cabazitaxel - Testicular Cancer | Phase 2 | Terminated | University Hospital, Akershus | 14 | 2015-06-01 | 2024-02-02 |
| Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors palifosfamide - Adult Central Nervous System Germ Cell Tumor, Adult Teratoma | Phase 2 | Terminated | Indiana University | 5 | 2013-02-01 | 2015-07-02 |
| Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload deferasirox - Iron Overload, Accelerated Phase Chronic Myelogenous Leukemia | Phase 2 | Terminated | City of Hope Medical Center | 1 | 2010-07-01 | 2019-06-18 |
| Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors carboplatin, dasatinib, etoposide phosphate - Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor | Phase 1 / Phase 2 | Terminated | City of Hope Medical Center | 7 | 2008-09-03 | 2023-07-14 |
| Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant anti-thymocyte globulin, rituximab, clofarabine - Cancer | Phase 2 | Terminated | Masonic Cancer Center, University of Minnesota | 12 | 2008-01-01 | 2017-12-28 |
| Trial of Paclitaxel, Gemcitabine and Cisplatin in Patients With Relapsing Germ Cell Cancer Paclitaxel, Cisplatin, Gemcitabine - Testicular Cancer | Phase 2 | Terminated | Copenhagen University Hospital, Rigshospitalet | 8 | 2007-09-01 | 2017-10-03 |
| Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer imatinib mesylate, therapeutic conventional surgery, laboratory biomarker analysis - Ovarian Dysgerminoma, Recurrent Malignant Testicular Germ Cell Tumor | Phase 2 | Terminated | National Cancer Institute (NCI) | 32 | 2002-06-01 | 2013-01-17 |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors filgrastim, carboplatin, cyclophosphamide - Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor | Phase 2 | Terminated | UNICANCER | 45 | 1998-03-01 | 2016-06-23 |
Testicular Neoplasms (11) · Burkitt Lymphoma (3) · Lymphoma, Large B-Cell, Diffuse (3) · Neoplasms, Germ Cell and Embryonal (3) · Neuroblastoma (3) · Ovarian Neoplasms (3) · Recurrence (3) · Breast Neoplasms (2) · Carcinoma, Ovarian Epithelial (2) · Hodgkin Disease (2) · Leukemia, Hairy Cell (2) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Leukemia, Myeloid, Acute (2) · Leukemia, Myelomonocytic, Chronic (2) · Leukemia, Neutrophilic, Chronic (2)
Endocrine Gland Neoplasms (11) · Endocrine System Diseases (11) · Genital Diseases (11) · Genital Diseases, Male (11) · Gonadal Disorders (11) · Male Urogenital Diseases (11) · Neoplasms by Site (11) · Urogenital Diseases (11) · Urogenital Neoplasms (11) · Genital Neoplasms, Male (10) · Neoplasms (10) · Neoplasms by Histologic Type (8) · Adnexal Diseases (5) · Female Urogenital Diseases (5)
Ifosfamide (3) · Carboplatin (2) · Paclitaxel (2) · Antilymphocyte Serum (1) · Blotting, Western (1) · Brentuximab Vedotin (1) · Cisplatin (1) · Clofarabine (1) · Cyclophosphamide (1) · Dasatinib (1) · Deferasirox (1) · Epirubicin (1) · Etoposide (1) · Filgrastim (1) · Gemcitabine (1)
City of Hope Medical Center (2) · Copenhagen University Hospital, Rigshospitalet (1) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (1) · Indiana University (1) · Masonic Cancer Center, University of Minnesota (1) · Nabil Adra (1) · Nasser Hanna, M.D. (1) · National Cancer Institute (NCI) (1) · UNICANCER (1) · University Hospital, Akershus (1)
United States (7) · Denmark (2) · Italy (2) · France (1) · Norway (1) · Sweden (1)
Christopher Ryan (1) · Costantine Albany, MD (1) · Gedske Daugaard, MD, DMSc (1) · Jakub Tolar, MD (1) · Jan Oldenburg, MD, PhD (1) · Judith K. Sato, MD (1) · Lawrence H Einhorn, MD (1) · Nasser Hanna, M.D. (1) · Pierre Biron, MD (1) · Vinod Pullarkat, MD (1)
P30CA033572 (1), U10CA031946 (1)